Musa Tariq - 13 Dec 2024 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Director
Signature
/s/ John G. Saia, as attorney-in-fact for Musa Tariq
Issuer symbol
GH
Transactions as of
13 Dec 2024
Net transactions value
-$81,200
Form type
4
Filing time
16 Dec 2024, 18:11:06 UTC
Previous filing
18 Nov 2024
Next filing
19 Dec 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH Common Stock Sale $81,200 -2,320 -46% $35.00 2,676 13 Dec 2024 Direct
transaction GH Common Stock Options Exercise $0 +250 +9.3% $0.000000 2,926 15 Dec 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH Restricted Stock Units Options Exercise $0 -250 -3.6% $0.000000 6,746 15 Dec 2024 Common Stock 250 $0.000000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The restricted stock units granted on March 6, 2023 vests over a four-year period. 25% of the shares subject to such award vested on the one-year anniversary of March 15, 2023, and the remaining 75% vests monthly for the three-year period thereafter.
F2 Not applicable for Restricted Stock Units.